Ladenburg Thalmann Financial Services’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio SCLN Stock Details SCLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-84	Closed	-$1K	–	4939
2016 Q1	$1K	Hold	84	–	–	﹤0.01%	4629
2015 Q4	$1K	Sell	84 -301	-78%	-$2.52K	﹤0.01%	4611
2015 Q3	$3K	Sell	385 -48	-11%	-$411	﹤0.01%	4192
2015 Q2	$4K	Buy	433 +412	+1,962%	+$3.75K	﹤0.01%	4178
2015 Q1	$0	Hold	21	–	–	﹤0.01%	4727
2014 Q4	$0	Buy	+21	New	+$170	﹤0.01%	4514
2013 Q4	–	Sell	-26	Closed	–	–	3926
2013 Q3	$0	Hold	26	–	–	﹤0.01%	3905
2013 Q2	$0	Buy	+26	New	+$124	﹤0.01%	3731

Other funds holding SCLN

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ladenburg Thalmann Financial Services's SCLN Position: Q2 2016 in Review

Ladenburg Thalmann Financial Services sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q2 2016, closing a stake of 84 shares — an estimated $1K sold.

Ladenburg Thalmann Financial Services first reported a position in SCLN in Q2 2013 and held it in 8 quarters. The position peaked at $4K in Q2 2015. 151 funds tracked by Wall St. Rank hold SCLN as of Q2 2016.

Ladenburg Thalmann Financial Services reported no remaining Sciclone Pharmaceuticals Inc position as of Q2 2016 after selling out during the quarter.
Ladenburg Thalmann Financial Services sold 84 Sciclone Pharmaceuticals Inc shares in Q2 2016, an estimated $1K.
Ladenburg Thalmann Financial Services first reported a position in Sciclone Pharmaceuticals Inc in Q2 2013 and held it in 8 quarters.
Ladenburg Thalmann Financial Services's Sciclone Pharmaceuticals Inc position peaked at $4K in Q2 2015.
151 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q2 2016.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q2 2016, filed 15 Aug 2016.